Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
N04BX02 - EntacaponeATC-DDD Version 2016. Source: WHO
N - Nervous System
N04 - Anti-Parkinson Drugs

This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.

The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.
No separate DDDs are established for oral depot formulations.

N04B - Dopaminergic Agents
N04BX - Other Dopaminergic Agents

This group comprises dopaminergic agents which cannot be classified in the preceding groups.
The combination of levodopa, decarboxylase inhibitor and COMT inhibitor is classified in N04BA - Dopa and dopa derivatives.

N04BX02 - Entacapone
1 gO 
2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home